Mid‐upper arm circumference is associated with liver steatosis and fibrosis in patients with metabolic‐associated fatty liver disease: A population based observational study

Xiaoxiao Wang, Xiaohe Li, Rui Jin, Jia Yang, Rui Huang, Lai Wei, Feng Liu, Huiying Rao – 12 May 2022 – Metabolic‐associated fatty liver disease (MAFLD) is a series of liver diseases based on liver steatosis and metabolic disorders. Steatosis, as the core factor in MAFLD diagnosis, and fibrosis, as the major determinant of adverse outcomes of MAFLD, need to be assessed simply and accurately. In this study, we explored the significance of mid‐upper arm circumference (MUAC) in evaluating liver steatosis and fibrosis in patients with MAFLD.

Online Learning Committee

The Online Learning Committee develops and implements AASLD online educational activities for healthcare providers with the goals of increasing scientific knowledge and addressing professional practice gaps by improving competence and performance, thereby improving the care of patients with liver disease.

AASLD Statement On Diversity and Call To Action

AASLD will take direct action to address discrimination and inequality in order to improve diversity within AASLD membership and the hepatology workforce and ensure equitable access to resources and opportunities for leadership. We will strive to create an environment where every member feels valued and respected and where those from underrepresented groups are able to influence policy. In conjunction with the Inclusion and Diversity Committee, the AASLD is committed to the following actions:

Subscribe to